{
  "thread": {
    "uuid": "c6e3c266426f5c72e871c2477385a7909e64bd87",
    "url": "https://www.defenseworld.net/2025/08/14/cormark-has-negative-outlook-of-cresco-labs-fy2025-earnings.html",
    "site_full": "www.defenseworld.net",
    "site": "defenseworld.net",
    "site_section": "https://www.defenseworld.net",
    "site_categories": [
      "media"
    ],
    "section_title": "Defense World",
    "site_title": "Defense World",
    "title": "Cormark Has Negative Outlook of Cresco Labs FY2025 Earnings",
    "title_full": "Cormark Has Negative Outlook of Cresco Labs FY2025 Earnings",
    "published": "2025-08-14T09:10:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 38342,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "c6e3c266426f5c72e871c2477385a7909e64bd87",
  "url": "https://www.defenseworld.net/2025/08/14/cormark-has-negative-outlook-of-cresco-labs-fy2025-earnings.html",
  "ord_in_thread": 0,
  "author": "Defense World Staff",
  "published": "2025-08-14T09:10:00.000+03:00",
  "title": "Cormark Has Negative Outlook of Cresco Labs FY2025 Earnings",
  "text": "Cresco Labs Inc. ( OTCMKTS:CRLBF – Free Report ) – Cormark dropped their FY2025 earnings per share (EPS) estimates for Cresco Labs in a research report issued to clients and investors on Monday, August 11th. Cormark analyst J. Pytlak now expects that the company will earn ($0.14) per share for the year, down from their previous forecast of ($0.07). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Cormark also issued estimates for Cresco Labs’ FY2026 earnings at ($0.06) EPS. Separately, Canaccord Genuity Group downgraded Cresco Labs from a “strong-buy” rating to a “moderate buy” rating in a research note on Tuesday, June 3rd. View Our Latest Analysis on Cresco Labs OTCMKTS CRLBF opened at $1.12 on Wednesday. Cresco Labs has a 12 month low of $0.43 and a 12 month high of $2.05. The company has a current ratio of 3.10, a quick ratio of 1.98 and a debt-to-equity ratio of 1.33. The stock’s fifty day moving average price is $0.60 and its 200-day moving average price is $0.70. The stock has a market cap of $547.49 million, a P/E ratio of -8.58 and a beta of 1.42. Cresco Labs ( OTCMKTS:CRLBF – Get Free Report ) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01). Cresco Labs had a negative net margin of 6.67% and a negative return on equity of 11.77%. The company had revenue of $163.62 million for the quarter, compared to analysts’ expectations of $162.00 million. ( Get Free Report )Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "negative",
  "categories": [
    "Health",
    "Science and Technology"
  ],
  "topics": [
    "Health->health organisation",
    "Health->medical profession",
    "Health->health insurance",
    "Science and Technology->economics",
    "Science and Technology->biomedical science"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [
    "https://www.marketbeat.com/arnreports/ReportTickerOptin.aspx?RegistrationCode=TickerHyperlink&Prefix=OTCMKTS&Symbol=CRLBF",
    "https://www.marketbeat.com/logos/cresco-labs-inc-logo-1200x675.PNG?v=20201026140920",
    "https://www.marketbeat.com/stocks/OTCMKTS/CRLBF/",
    "https://www.marketbeat.com/stocks/OTCMKTS/CRLBF/earnings/",
    "https://www.marketbeat.com/logos/cresco-labs-inc-logo-1200x675.PNG",
    "https://www.marketbeat.com/arnreports/ReportTickerOptin.aspx",
    "https://marketbeat.com/arnreports/ReportTickerOptin.aspx?RegistrationCode=TickerHyperlink&Prefix=OTCMKTS&Symbol=CRLBF",
    "https://marketbeat.com/logos/cresco-labs-inc-logo-1200x675.PNG?v=20201026140920",
    "https://www.marketbeat.com/stocks/OTCMKTS/CRLBF/earnings",
    "https://www.marketbeat.com/stocks/OTCMKTS/CRLBF",
    "https://marketbeat.com/stocks/OTCMKTS/CRLBF/",
    "https://marketbeat.com/stocks/OTCMKTS/CRLBF/earnings/"
  ],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [
      {
        "name": "J. Pytlak",
        "sentiment": "none"
      }
    ],
    "locations": [],
    "organizations": [
      {
        "name": "Cresco Labs Inc.",
        "sentiment": "negative",
        "tickers": []
      },
      {
        "name": "Canaccord Genuity Group",
        "sentiment": "none",
        "tickers": [
          {
            "ticker": "CF",
            "exchange": "TSX"
          }
        ]
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-08-14T09:19:43.937+03:00",
  "updated": "2025-08-14T09:32:05.000+03:00"
}